| P50 | author | Kajsa Paulsson | Q43156682 |
| P2093 | author name string | Bertil Johansson | |
| | Mikael Behrendtz | |
| | Anders Castor | |
| | Linda Olsson | |
| | Andrea Biloglav | |
| | Ferras Albitar | |
| P2860 | cites work | Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia | Q43221788 |
| | An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. | Q43922213 |
| | Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor | Q44519043 |
| | IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia. | Q45326639 |
| | Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome | Q46355702 |
| | A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia. | Q46677100 |
| | Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. | Q46933149 |
| | FLT3 mutations in a 10 year consecutive series of 177 childhood acute leukemias and their impact on global gene expression patterns | Q46944335 |
| | Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. | Q50860875 |
| | ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia. | Q52882383 |
| | Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. | Q53307880 |
| | BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros | Q57734316 |
| | Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols | Q58861726 |
| | A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma | Q71806450 |
| | Location and function of linker histones | Q77659483 |
| | A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study | Q24651897 |
| | Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 |
| | IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report | Q27851487 |
| | IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. | Q27851563 |
| | Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia. | Q27852421 |
| | Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment | Q28202932 |
| | The Ikaros gene is required for the development of all lymphoid lineages | Q28594316 |
| | Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia | Q29614324 |
| | Control of lymphocyte development by the Ikaros gene family | Q33632444 |
| | Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles | Q33938184 |
| | Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia | Q34314927 |
| | Biology, risk stratification, and therapy of pediatric acute leukemias: an update | Q34764504 |
| | Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. | Q35741581 |
| | Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome | Q35876592 |
| | Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study | Q35885293 |
| | Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia | Q36174146 |
| | Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project | Q36542815 |
| | IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol | Q36862420 |
| | Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. | Q36862511 |
| | What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? | Q37060647 |
| | Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia | Q37172988 |
| | Genetic loss of SH2B3 in acute lymphoblastic leukemia | Q37215146 |
| | JAK mutations in high-risk childhood acute lymphoblastic leukemia | Q37224111 |
| | Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. | Q37226741 |
| | IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan | Q39730823 |
| | Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia | Q39814053 |
| | Ikaros isoform x is selectively expressed in myeloid differentiation. | Q40665471 |
| | Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis | Q42583762 |
| P433 | issue | 5 | |
| P921 | main subject | mutation | Q42918 |
| | lymphoblastic leukemia | Q18553852 |
| P304 | page(s) | 315-325 | |
| P577 | publication date | 2015-02-26 | |
| P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
| P1476 | title | Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1 | |
| P478 | volume | 54 | |